by Eric Christianson | Mar 18, 2020 | Clinical Pharmacy News and New Drug Updates
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as...
by Eric Christianson | Mar 15, 2020 | NAPLEX
Hey all, thanks so much for supporting the blog as well as the podcast! I’m amazed at how many people come to pick up a few pearls or listen to the drug of the week. Because of your support, I like to give annual sweet deals on our content! Today is the day for...
by Eric Christianson | Mar 11, 2020 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Many patients will take acetaminophen for their pain management. It is cheap, somewhat effective, and typically pretty safe at normal dosages. There are potential downsides when it comes to acetaminophen. Let me outline a couple of common mistakes with acetaminophen....
by Eric Christianson | Mar 8, 2020 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Tapering benzodiazepines or any drug for that matter is a bit of an art. Sure we do have some evidence on these types of topics, but we can’t also schedule a taper schedule perfectly based upon a percentage of the dose. Dosage forms and the patients themselves...
by Eric Christianson | Mar 4, 2020 | Long Term Care Consultant Pharmacist Education and Information, Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I received a question the other day about the use of bisphosphonates in patients who may have a limited life expectancy but have osteoporosis or are at risk for osteoporosis. It is a very good question and that determination is going to be made on a case by case...